HOME >> MEDICINE >> NEWS
Rensselaer to open new Terahertz Research Center

TROY, N.Y. -- Rensselaer Polytechnic Institute will mark the expansion of its terahertz research facilities with a gathering of pioneers and other experts in the field, for a discussion of the history and promise of this emerging technology.

The terahertz (THz) frequency range -- or "T-rays" -- presents the next frontier in imaging science and technology. Researchers at Rensselaer have used advanced THz technology to uncover small defects in the foam used for space shuttle insulation. Terahertz waves also offer enormous potential to find answers to problems as varied as asbestos or radiation contamination, or to search for landmines, plastic explosives, or weapons. There are also potential applications in medical imaging, agriculture, forensic science, and food safety.

President Shirley Ann Jackson, Dean of Science Joseph Flaherty, Physics Chair Gwo-Ching Wang, Professor Xi-Cheng Zhang, and honored guests will join the Rensselaer community in dedicating the new W. M. Keck Laboratory for Terahertz Science in the Center for Terahertz Research at Rensselaer. The Dec. 5 ceremonies will include a "Conversation on Terahertz" and a "Technical Symposium on Terahertz Research." The programs will be held in the George M. Low Center for Industrial Innovation, Room 4050, beginning at 10:45 a.m., and are open to the public

Zhang, along with two other distinguished pioneers in terahertz research Daniel Grischkowsky, Oklahoma State University; and Yuen-Ron Shen, the University of California at Berkeley and Lawrence Berkeley National Laboratory will participate in the "Conversation on Terahertz Research," moderated by President Jackson beginning at 11 a.m. They will discuss the history and potential applications of terahertz research, and take questions from the audience.

The "Technical Symposium on Terahertz Research," from 1 to 4 p.m., will include an overview of terahertz science, its history and promise, a review
'"/>

Contact: Theresa Bourgeois
bourgt@rpi.edu
518-276-2840
Rensselaer Polytechnic Institute
3-Dec-2003


Page: 1 2 3

Related medicine news :

1. Rensselaer researcher receives $2.1 million grant to develop treatment for anthrax
2. Rensselaer awarded NY state funding for alcohol/substance abuse education
3. New system created by Rensselaer group speeds the mapping of blood vessel networks in live tumors
4. Rensselaer research team sheds light on a good nights sleep for those with Alzheimers
5. Rensselaer researchers seeing farther and faster with terahertz (Thz) imaging
6. Researchers search for first sign of congestive heart failure
7. Research offers hope of new treatments for liver damage
8. Research suggests possible blood test for multiple sclerosis
9. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
10. 2005 Award for Basic Research in Biological Mineralization
11. 2005 Craniofacial Biology Research Award

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rensselaer open new Terahertz Research Center

(Date:3/6/2015)... Protein identification is increasingly being ... science research including drug discovery, diagnostics, immunology and ... was valued at $1,569.00 million in 2014 and ... 10.63% to reach $2,600.28 million in 2019. , ... protein based on protein size, shape, sequence and ...
(Date:3/6/2015)... As healthcare providers create one ... from disparate systems, they are using OnBase by ... efficiency. Enterprise content management (ECM) solutions ... IT solutions, including electronic medical records (EMR), enterprise ... , The following organizations have recently integrated ...
(Date:3/6/2015)... March 06, 2015 Saving Moses, a ... the world is traveling to Angola, Africa March 7-14 ... their malnutrition program. , This will be the organizations ... Angola, demonstrating their commitment to the region’s population by ... team will engage with the mothers and babies of ...
(Date:3/6/2015)... 06, 2015 Follow us on ... pharmacokinetics of a drug refers to testing of absorption, ... an organism. When toxicity studies are clubbed together with ... ADME/Tox. Increasing focus on lowering costs and time during ... worldwide. The traditional drug development model uses toxicity and ...
(Date:3/6/2015)... March 06, 2015 “On Tap” takes the ... the grand stage, to the silver screen and to modern ... precision toe-tapping numbers and their famous eye-high kicks! Producers, directors ... rich history of tap dancing in this robust show, showcasing ... of the United States. , “On Tap” is proud ...
Breaking Medicine News(10 mins):Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 2Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 3Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2
(Date:3/6/2015)... , March 6, 2015  Palatin Technologies, Inc. (NYSE MKT: ... 27 th Annual ROTH Conference on Wednesday, March 11, ... held at the Ritz Carlton Laguna Niguel in ... Spana , Ph.D., President and Chief Executive Officer of Palatin ... programs. About Palatin Technologies, Inc. ...
(Date:3/6/2015)... , March 6, 2015   Hospira, Inc. ... Food and Drug Administration (FDA) on today,s FDA approval of ... . This is a watershed moment for improving patient access ... leading global provider of biosimilars, Hospira has seen first-hand the ... a proud participant in these early stages of the development ...
(Date:3/6/2015)... March 6, 2015  Aethlon Medical, Inc. (OTCQB:AEMD), the ... diseases and cancer, today announced that James A. ... present a corporate overview at the 27th Annual ROTH ... time.  Aethlon was previously scheduled to present at 5:30 ... will be held at The Ritz-Carlton Hotel in ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2
Cached News: